Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. | Clinical Cancer Research - 0 views
-
Nathan Goodyear on 27 Aug 20Great phase 1 pharmacokinetic study on Quercetin dosing.